Ryousuke Satou Selected Research

Inflammation (Inflammations)

5/2012

Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryousuke Satou Research Topics

Disease

19	Hypertension (High Blood Pressure) 01/2020 - 05/2008
5	Body Weight (Weight, Body) 01/2016 - 07/2005
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 11/2010
3	IGA Glomerulonephritis (IGA Nephropathy) 08/2009 - 06/2007
2	Diabetes Mellitus 01/2020 - 01/2019
2	Hyperglycemia 01/2020 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 12/2019 - 01/2019
2	Glomerulonephritis 10/2014 - 03/2011
2	Kidney Diseases (Kidney Disease) 10/2014 - 05/2008
2	Nephritis 03/2011 - 05/2008
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Albuminuria 12/2019
1	Neoplasms (Cancer) 08/2015
1	Inflammation (Inflammations) 05/2012
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 04/2011
1	Fibrosis (Cirrhosis) 04/2011
1	Proteinuria 03/2011
1	Chronic Renal Insufficiency 09/2008

Drug/Important Bio-Agent (IBA)

16	AngiotensinogenIBA 01/2020 - 06/2007
9	Angiotensin IIIBA 01/2020 - 07/2005
6	ReninIBA 08/2015 - 09/2008
5	SodiumIBA 01/2020 - 09/2008
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2010
3	CytokinesIBA 10/2018 - 05/2012
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2011 - 02/2009
3	Immunoglobulin A (IgA)IBA 08/2009 - 05/2008
2	SaltsIBA 01/2020 - 07/2012
2	Messenger RNA (mRNA)IBA 01/2019 - 10/2014
2	AngiotensinsIBA 01/2017 - 02/2009
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 05/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2012 - 10/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2009 - 05/2009
2	CreatinineIBA 02/2009 - 09/2008
2	Angiotensin IIIIBA 12/2005 - 07/2005
1	Chymases (Chymase)IBA 12/2019
1	CanagliflozinIBA 01/2019
1	Advanced Glycation End ProductsIBA 01/2019
1	8-epi-prostaglandin F2alphaIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Type 1 Angiotensin ReceptorIBA 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2014
1	Plasminogen Activators (Plasminogen Activator)IBA 10/2014
1	aliskiren FDA Link 10/2014
1	rho-Associated KinasesIBA 03/2014
1	InterferonsIBA 05/2012
1	CCR2 ReceptorsIBA 03/2011
1	Angiotensin IIBA 03/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2011
1	antiglomerular basement membrane antibodyIBA 03/2011
1	Angiotensin II Type 1 Receptor BlockersIBA 03/2011
1	Phosphotransferases (Kinase)IBA 11/2010
1	PotassiumIBA 09/2008
1	Biomarkers (Surrogate Marker)IBA 09/2008

Therapy/Procedure

1	Therapeutics 03/2011